Clinitech Laboratory Ltd
Founded in 1990, Clinitech Laboratory Limited provides diagnostic and health testing and services.[1]
- Market Cap ₹ 10.5 Cr.
- Current Price ₹ 46.2
- High / Low ₹ 99.0 / 29.2
- Stock P/E 31.0
- Book Value ₹ 38.7
- Dividend Yield 0.00 %
- ROCE 8.15 %
- ROE 5.49 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.19 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.6% over last 3 years.
- Debtor days have increased from 43.6 to 68.3 days.
- Working capital days have increased from 34.4 days to 115 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 4.55 | 6.38 | 6.35 | 6.40 | 8.23 | |
| 3.72 | 5.31 | 4.99 | 5.41 | 7.40 | |
| Operating Profit | 0.83 | 1.07 | 1.36 | 0.99 | 0.83 |
| OPM % | 18.24% | 16.77% | 21.42% | 15.47% | 10.09% |
| 0.04 | 0.07 | 0.02 | 0.04 | 0.23 | |
| Interest | 0.08 | 0.06 | 0.07 | 0.09 | 0.06 |
| Depreciation | 0.25 | 0.38 | 0.45 | 0.44 | 0.45 |
| Profit before tax | 0.54 | 0.70 | 0.86 | 0.50 | 0.55 |
| Tax % | 25.93% | 27.14% | 29.07% | 26.00% | 29.09% |
| 0.40 | 0.51 | 0.61 | 0.37 | 0.39 | |
| EPS in Rs | 6.00 | 3.40 | 4.07 | 2.20 | 1.71 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -13% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.67 | 1.50 | 1.50 | 1.68 | 2.28 |
| Reserves | 0.72 | 0.35 | 0.88 | 1.87 | 6.55 |
| 0.54 | 0.89 | 1.03 | 0.87 | 0.00 | |
| 0.80 | 0.94 | 2.62 | 1.19 | 1.88 | |
| Total Liabilities | 2.73 | 3.68 | 6.03 | 5.61 | 10.71 |
| 0.84 | 1.65 | 1.33 | 1.71 | 2.12 | |
| CWIP | 0.08 | 0.41 | 0.56 | 0.94 | 1.01 |
| Investments | 0.09 | 0.14 | 2.02 | 0.07 | 0.07 |
| 1.72 | 1.48 | 2.12 | 2.89 | 7.51 | |
| Total Assets | 2.73 | 3.68 | 6.03 | 5.61 | 10.71 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0.38 | 0.96 | 1.25 | -1.28 | -0.88 | |
| 0.54 | -1.47 | -0.65 | 0.75 | -0.73 | |
| -0.88 | 0.29 | 0.09 | 0.45 | 3.98 | |
| Net Cash Flow | 0.04 | -0.22 | 0.68 | -0.08 | 2.37 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 44.92 | 20.60 | 28.17 | 34.22 | 68.30 |
| Inventory Days | 32.21 | 40.28 | 43.68 | 92.91 | 124.01 |
| Days Payable | 164.61 | 130.90 | 124.79 | 116.14 | 147.40 |
| Cash Conversion Cycle | -87.48 | -70.03 | -52.95 | 10.99 | 44.90 |
| Working Capital Days | 43.32 | -4.58 | -33.34 | 21.67 | 114.87 |
| ROCE % | 32.55% | 30.24% | 14.81% | 8.15% |
Business Profile[1] The company performs over 150 tests in its centers, categorized into Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests, and Histopathology Tests.